🟢 Clover Health is trading 4.43% up on October 28, 2026, after Needham's Buy initiation

Clover Health is trading at $4.83, up 4.43%, after Needham initiated coverage with a Buy rating and a $6 price target.

• CNBC reported the initiation on October 28; Needham cited Clover’s cohort economics and long-term earnings opportunity.
• Clover Health’s third-quarter results are scheduled for November 4, a near-term event for investors to watch. The broad market was only modestly higher, making the analyst initiation the clearer explanation for the move.